GI Innovation, Inc. (KOSDAQ:358570)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,360
-440 (-4.07%)
May 20, 2026, 3:30 PM KST
Market Cap665.50B -27.0%
Revenue (ttm)5.84B +23,943.4%
Net Income-35.13B
EPS-604.00
Shares Out64.24M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume700,017
Average Volume715,524
Open10,800
Previous Close10,800
Day's Range10,080 - 10,810
52-Week Range10,110 - 24,900
Betan/a
RSI27.12
Earnings Daten/a

About GI Innovation

GI Innovation, Inc. engages in the development of biopharmaceutical products. Its product pipeline includes G-101, G-102, G-301, and G-108. The company was founded by Jang Myoung-ho on July 19, 2017 and is headquartered in Seoul, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 358570
Full Company Profile

Financial Performance

In 2025, GI Innovation's revenue was 5.84 billion, an increase of 23943.39% compared to the previous year's 24.28 million. Losses were -35.13 billion, -40.23% less than in 2024.

Financial Statements